EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GPSM2 Promotes Pancreatic Cancer Progression Through METTL3 ‐Mediated m6A Modification of YAP1 mRNA

Jiajun Xiu iD, Li Qiao, Miaomiao Li, Xiaoan Hu, Zixuan Shen, Rui Yang, Hairu Zhang, Zhe Dong, Xuelei Liu iD, Yinghui Zhang iD

Journal of Cellular and Molecular Medicine · 2026-06 · 30 (11)

DOI: 10.1111/jcmm.71224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 02.06.2026. Verfasst von Jiajun Xiu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Intracellular Signaling Peptides and Proteins, Methyltransferases, Pancreatic Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Hospital Fund of the First Hospital of Lanzhou University, The Lanzhou Science and Technology Planning Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer poses a major therapeutic challenge due to its insidious onset and difficulty in early diagnosis. G‐protein signalling modulator 2 (GPSM2), a member of the G‐protein signalling regulator family, is highly expressed in various tumour tissues; however, its role in pancreatic cancer remains largely undefined. Yes‐associated protein 1 (YAP1), a transcriptional co‐activator, has been recognised as a central node in the growth‐promoting signalling pathways of pancreatic cancer. Nevertheless, whether GPSM2 contributes to pancreatic cancer progression through the regulation of YAP1 has not yet been elucidated. In this study, transcriptome analysis of 183 pancreatic cancer patients from The Cancer Genome Atlas (TCGA) dataset identified GPSM2 as a survival‐associated gene in pancreatic cancer. Functionally, we demonstrated that GPSM2 promotes colony formation and invasion of pancreatic cancer cells and was found to be mechanistically linked to the regulation of YAP1. Molecular investigations revealed that GPSM2 significantly upregulated YAP1 mRNA levels. Further analysis demonstrated that GPSM2 enhanced the N6‐methyladenosine (m6A) modification of YAP1 mRNA in a METTL3‐dependent manner. The KH3‐4 domain of the m6A reader proteins IGF2BP2 and IGF2BP3 specifically recognised the m6A‐modified YAP1 transcripts, thereby stabilising YAP1 mRNA and increasing YAP1 protein expression, which in turn promoted colony formation and invasion in pancreatic cancer cells. These findings provide novel insights into the molecular mechanisms underlying pancreatic cancer progression and may offer promising therapeutic targets for future intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsMethyltransferasesPancreatic NeoplasmsRNA MethylationAnimalsHumansAdenosineCell Line, TumorCell ProliferationDisease ProgressionGene Expression Regulation, NeoplasticRNA, MessengerRNA-Binding ProteinsTranscription FactorsYAP-Signaling Proteins

Stichwörter der Autor:innen

GPSM2IGF2BP2/3METTL3YAP1m6Apancreatic cancer

Substanzen

Adaptor Proteins, Signal TransducingAdenosineIGF2BP3 protein, humanIntracellular Signaling Peptides and ProteinsMethyltransferasesMETTL3 protein, humanN-methyladenosineRNA, MessengerRNA-Binding ProteinsTranscription Factors

Autor:innen und Institutionen

  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Laboratory Medical Center, General Hospital of Northern Theater Command, Shenyang, People's Republic of China.
  • Medicine Laboratory Centre, The First Hospital of Lanzhou University, Lanzhou, People's Republic of China.
  • Center of Reproductive Medicine, Shenyang Women's and Children's Hospital, Shenyang, People's Republic of China.
  • Department of Plastic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
  • Department of Pathology, General Hospital of Northern Theater Command, Shenyang, People's Republic of China.

ORCID-Profile: Jiajun Xiu, Xuelei Liu, Yinghui Zhang

Förderung

  • The Hospital Fund of the First Hospital of Lanzhou University
  • The Lanzhou Science and Technology Planning Project

Zitieren

APA

Xiu, J., Qiao, L., Li, M., Hu, X., Shen, Z., Yang, R., Zhang, H., Dong, Z., Liu, X., & Zhang, Y. (2026). GPSM2 Promotes Pancreatic Cancer Progression Through METTL3 ‐Mediated m6A Modification of YAP1 mRNA. Journal of Cellular and Molecular Medicine, 30(11). https://doi.org/10.1111/jcmm.71224

Vancouver

Xiu J, Qiao L, Li M, Hu X, Shen Z, Yang R, et al. GPSM2 Promotes Pancreatic Cancer Progression Through METTL3 ‐Mediated m6A Modification of YAP1 mRNA. Journal of Cellular and Molecular Medicine. 2026;30(11). doi:10.1111/jcmm.71224

BibTeX
@article{Xiu2026,
  author = {Xiu, Jiajun and Qiao, Li and Li, Miaomiao and Hu, Xiaoan and Shen, Zixuan and Yang, Rui and Zhang, Hairu and Dong, Zhe and Liu, Xuelei and Zhang, Yinghui},
  title = {GPSM2 Promotes Pancreatic Cancer Progression Through METTL3 ‐Mediated m6A Modification of YAP1 mRNA},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {11},
  doi = {10.1111/jcmm.71224}
}
Kostenlos starten →